Why do some people develop ankylosing spondylitis (AS) while others do not? The answer lies in a combination of inherited susceptibility and environmental triggers. Genetics set the stage, but infections, gut bacteria, and lifestyle factors often pull the trigger. Understanding these pieces helps explain how the disease begins and what can be done to reduce risk or slow progression.
Genetic background: HLA-B27 and risk
HLA-B27 is a genetic marker found in the majority of people diagnosed with AS. Its presence greatly increases susceptibility, but it is not a guarantee of disease.
- Common in AS patients: HLA-B27 is detected in a high percentage of individuals with ankylosing spondylitis.
- Not determinative: Most people who carry HLA-B27 never develop AS. Carrying the gene means higher risk—studies estimate several-fold increased likelihood compared with non-carriers—but additional factors are usually needed to start the disease process.
- Why HLA-B27 matters: The HLA-B27 molecule shapes how the immune system presents pieces of proteins to immune cells. Small differences in structure can change immune responses and help explain why inflammation targets the spine and entheses (where tendons and ligaments attach to bone).
Environmental triggers that matter
Genetics provide vulnerability. Environmental factors provide the stimulus. Several triggers have been implicated in starting or worsening AS.
Smoking
Smoking increases both risk and severity. People who smoke are more likely to develop AS and tend to experience worse symptoms and faster progression. Quitting smoking is one of the most effective lifestyle steps to lower risk and improve outcomes.
Infections and viruses
Certain infections can act as initiating events. Viral infections such as chikungunya have been linked to post-infectious inflammatory arthritis and can unmask or worsen spondyloarthritis in susceptible people.
Gut bacteria: Klebsiella, Proteus, and the gut-spine connection
The gut plays a central role in many cases of AS. Specific intestinal bacteria—most notably Klebsiella and Proteus species—have been repeatedly associated with spondylitis.
- Molecular mimicry: Some bacterial proteins resemble parts of the HLA-B27 molecule or other human proteins. When the immune system responds to the bacteria, it can mistakenly attack the body’s own tissues, including joints and spinal entheses.
- Gut dysbiosis: An imbalance in the gut microbiome can promote chronic immune activation. A leaky gut or recurrent gut infections may expose immune cells to bacterial components that sustain inflammation.
▶
How these factors combine to start AS
Think of AS as a multi-step process:
- Genetic susceptibility: Presence of HLA-B27 or other genetic risk factors creates a predisposed immune environment.
- An environmental trigger: Smoking, a viral infection, or gut bacteria like Klebsiella provides the stimulus that activates the immune system.
- Immune cross-reaction: Molecular mimicry or persistent gut-driven immune activation causes immune cells to target spinal structures.
- Chronic inflammation: Once established, inflammation at the sacroiliac joints and entheses can become self-perpetuating, leading over time to pain, stiffness, and in some cases, fusion of the spine.
Practical steps: testing, prevention, and management
Because AS arises from a mix of genetics and environment, interventions target both sides of that equation.
- Testing: HLA-B27 testing can clarify genetic risk, but a positive result is not a diagnosis by itself. Clinical evaluation and imaging are essential.
- Quit smoking: Stopping smoking reduces risk and slows disease progression.
- Address gut health: Treating gut infections, improving diet, and addressing dysbiosis may help reduce immune activation. Discuss appropriate investigations with a clinician.
- Treat infections promptly: Infections that trigger immune responses should be diagnosed and treated to reduce the chance of chronic inflammation.
- Specialist care: Early referral to a rheumatologist is important. Treatment options range from NSAIDs and physiotherapy to targeted biologic therapies for moderate to severe disease.
- Active lifestyle and physiotherapy: Regular exercise and posture-preserving activities help maintain spinal mobility and quality of life.
Key takeaways
- HLA-B27 is a major risk factor, not a verdict. Many carriers remain healthy, so the gene alone does not explain the disease.
- Environmental factors matter. Smoking, certain infections, and gut bacteria such as Klebsiella and Proteus can trigger or aggravate AS through mechanisms like molecular mimicry and chronic gut-driven immune activation.
- Early action helps. Testing, lifestyle change, addressing gut and infectious triggers, and timely specialist treatment can reduce risk and improve outcomes.
Understanding the interplay between genes and the environment clarifies why ankylosing spondylitis develops in some people and not others. Genetics create susceptibility; microbes, viruses, and habits push the immune system toward chronic inflammation. Intervening early and addressing both genetic risk and modifiable triggers gives the best chance to prevent progression and preserve function.
